Tin tức & Cập nhật

Chỉ hiển thị Multimedia

Obesity impacts symptom severity, prednisone dosing in PMR

27 Feb 2025

Obesity appears to have an impact on both symptom severity and the use of prednisone in patients with polymyalgia rheumatica (PMR), suggests a study. This is potentially driven by subjective pain perception rather than increased inflammation.

Obesity impacts symptom severity, prednisone dosing in PMR

27 Feb 2025

Upper extremity-related disabilities in early RA increase after 2 years

26 Feb 2025

Disability related to the upper extremities (UEs) in early rheumatoid arthritis (RA) is significantly decreased in the first 6 months, but this tends to significantly rise after 2 years, reports a study.

Upper extremity-related disabilities in early RA increase after 2 years

26 Feb 2025

$Older adults with autoimmune diseases at increased fracture risk when using PPIs, steroids$

Older adults with autoimmune diseases at increased fracture risk when using PPIs, steroids

24 Feb 2025

Proton pump inhibitors (PPIs) are linked to heightened risk of fractures among older adults with autoimmune rheumatic and gastrointestinal diseases, especially when PPIs are used in conjunction with glucocorticoids, according to a study.

Older adults with autoimmune diseases at increased fracture risk when using PPIs, steroids

24 Feb 2025

FMT of no benefit in systemic sclerosis patients with lower GI tract involvement

09 Feb 2025

Faecal microbiota transplantation (FMT) with standardized anaerobic cultivated human intestinal microbiome is safe but does not appear to be efficacious in patients with systemic sclerosis experiencing lower gastrointestinal (GI) tract symptoms, according to a phase II study.

FMT of no benefit in systemic sclerosis patients with lower GI tract involvement

09 Feb 2025

Selexipag demonstrates therapeutic potential in systemic sclerosis vasculopathy

08 Feb 2025

Preliminary data from an observational case–control study have shown that selexipag is safe and effective in the treatment of systemic sclerosis vasculopathy, particularly digital ulcers (DUs) and Raynaud phenomenon (RP).

Selexipag demonstrates therapeutic potential in systemic sclerosis vasculopathy

08 Feb 2025

Baricitinib cuts need for oral steroids in polymyalgia rheumatica

28 Jan 2025

In the treatment of patients with polymyalgia rheumatica, the Janus kinase 1/2 inhibitor baricitinib helps reduce the need to take oral glucocorticoids to have low disease activity while having no new safety signals, according to data from the randomized, double-blind BACHELOR trial.

Baricitinib cuts need for oral steroids in polymyalgia rheumatica

28 Jan 2025

Weather variation affects disease activity, outcomes in PsA

27 Jan 2025

Weather changes tend to influence the clinical profile of patients with psoriatic arthritis (PsA), reveals a recent study, which examined weather variations through subjective and objective patient-reported outcomes (PROs) matched with those with PsA.

Weather variation affects disease activity, outcomes in PsA

27 Jan 2025

Bimekizumab eases pain, morning stiffness in axSpA patients

27 Jan 2025 bởi

Treatment with bimekizumab quickly relieves pain and morning stiffness among patients with axial spondyloarthritis (axSpA), as shown in a study. Such improvements persist through week 52.

Bimekizumab eases pain, morning stiffness in axSpA patients

27 Jan 2025

CV events during pregnancy up risk of preterm birth, SGA

26 Jan 2025

Cardiovascular (CV) events during pregnancy appear to moderately increase the risk of adverse pregnancy outcomes (APOs), such as preterm birth, small for gestational age (SGA), or both, reports a recent study.

CV events during pregnancy up risk of preterm birth, SGA

26 Jan 2025

Infliximab does not help with chronic low back pain-related disability

26 Jan 2025

In the treatment of patients with moderate-to-severe chronic low back pain, the use of infliximab does not yield meaningful reductions in pain-related disability when compared with placebo, as shown in a study.

Infliximab does not help with chronic low back pain-related disability

26 Jan 2025

Tin tức & Cập nhật

Xem bài viết Khớp

Xem

Chuyên ngành:

Obesity impacts symptom severity, prednisone dosing in PMR

Obesity impacts symptom severity, prednisone dosing in PMR

Upper extremity-related disabilities in early RA increase after 2 years

Upper extremity-related disabilities in early RA increase after 2 years

Older adults with autoimmune diseases at increased fracture risk when using PPIs, steroids

Older adults with autoimmune diseases at increased fracture risk when using PPIs, steroids

FMT of no benefit in systemic sclerosis patients with lower GI tract involvement

FMT of no benefit in systemic sclerosis patients with lower GI tract involvement

Selexipag demonstrates therapeutic potential in systemic sclerosis vasculopathy

Selexipag demonstrates therapeutic potential in systemic sclerosis vasculopathy

Baricitinib cuts need for oral steroids in polymyalgia rheumatica

Baricitinib cuts need for oral steroids in polymyalgia rheumatica

Weather variation affects disease activity, outcomes in PsA

Weather variation affects disease activity, outcomes in PsA

Bimekizumab eases pain, morning stiffness in axSpA patients

Bimekizumab eases pain, morning stiffness in axSpA patients

CV events during pregnancy up risk of preterm birth, SGA

CV events during pregnancy up risk of preterm birth, SGA

Infliximab does not help with chronic low back pain-related disability

Infliximab does not help with chronic low back pain-related disability